The effects of botulinum toxin type A on muscle blood perfusion and metabolism

Plastic and Reconstructive Surgery

Volumn 120, Issue 7, 2007, Pages 1823-1833

  Matic, Damir B ^a,b   Lee, Ting Y ^a   Wells, R Glenn ^a   Gan, Bing S ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; FLUORODEOXYGLUCOSE F 18; IOHEXOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CAPILLARY PERMEABILITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; FACE SURGERY; FEMALE; GLUCOSE TRANSPORT; MASSETER MUSCLE; MUSCLE METABOLISM; MUSCLE PERFUSION; NONHUMAN; PARALYSIS; PARAMETER; PERMEABILITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RABBIT; RHYTIDOPLASTY; WRINKLE;

ANIMALS; BLOOD VOLUME; BOTULINUM TOXIN TYPE A; CAPILLARY PERMEABILITY; CEREBROVASCULAR CIRCULATION; FEMALE; FLUORODEOXYGLUCOSE F18; IMAGING, THREE-DIMENSIONAL; INJECTIONS, INTRAMUSCULAR; MASSETER MUSCLE; NEUROMUSCULAR AGENTS; ORGAN SIZE; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RANDOM ALLOCATION; REGIONAL BLOOD FLOW; SINGLE-BLIND METHOD; TOMOGRAPHY, X-RAY COMPUTED;

EID: 37349121107     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000287135.17291.2f     Document Type: Article

References (25)

1. Cui, M., Khanijou, S., Rubino, J., and Aoki, K. R. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 107: 125, 2004.
2. Loder, E., and Biondi, D. Use of botulinum toxins for chronic headaches: A focused review. Clin. J. Pain 18: 169, 2002.
3. Göbel, H., Heinze, A., Heinze-Kuhn, K., and Austermann, K. Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain 91: 195, 2001.
4. Huang, W., Foster, J. A., and Rogachefsky, A. S. Pharmacology of botulinum toxin. J. Am. Acad. Dermatol. 43: 249, 2000.
5. Aoki, K. R. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 43: 9, 2003.
6. Ishikawa, H., Mitsui, Y., Yoshitomi, T., et al. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn. J. Ophthalmol. 44: 106, 2000.
7. Welch, M. J., Purkiss, J. R., and Foster, K. A. Sensitivity of embryonic rat dorsal ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 38: 245, 2000.
8. Tarabal, O., Caldero, J., Ribera, J., et al. Regulation of motoneuronal calcitonin gene-related peptide (CGRP) during axonal growth and neuromuscular synaptic plasticity induced by botulinum toxin in rats. Eur. J. Neurosci. 8: 829, 1996.
9. Lee, T., Purdie, T. G., and Stewart, E. CT imaging of angiogenesis. Q. J. Nucl. Med. 47: 171, 2003.
10. Lee, T. Functional CT: Physiological models. Trends Biotechnol. 20: 3, 2002.
11. Cencic, A., Nabavi, D. G., Craen, R., et al. Dynamic CT measurement of cerebral blood flow: A validation study. A.J.N.R. Am. J. Neuroradiol. 20: 65, 1999.
12. Johnson, J. A., and Wilson, T. A. A model for capillary exchange. Am. J. Physiol. 210: 1299, 1966.
13. St. Lawerence, K., and Lee, T.-Y. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain II: Experimental validation. J. Cereb. Blood Flow Metab. 18: 1378, 1998.
14. Valk, P. E., Bailey, D. L., Townsend, D. W., et al. Positron Emission Tomography: Basic Science and Clinical Practice. London: Springer, 2003.
15. Durham, P. L., Cady, R., and Cady, R. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: Implications for migraine therapy. Headache 44: 35, 2004.
16. Guyuron, B., Tucker, T., and Kriegler, J. Botulinum toxin A and migraine surgery. Plast. Reconstr. Surg. 112: 171, 2003.
17. Borodic, G. E., Ferrante, R., Pearce, L. B., and Smith, K. Histologic assessment of dose-related diffusion and muscle fibre response after therapeutic botulinum A toxin injections. Mov. Disord. 9: 31, 1994.
18. Filippi, G. M., Errico, P., Santarelli, R., et al. Botulinum A toxin effects on rat jaw muscle spindle. Acta Otolaryngol. 113: 400, 1993.
19. Borodic, G. E., Joseph, M., Fay, L., et al. Botulinum A toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxin spread. Head Neck 12: 392, 1990.
20. Borodic, G. E., and Ferrante, R. Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J. Clin. Neuroophthalmol. 12: 121, 1992.
21. Von Lindern, J. J., Niederhagen, B., Appel, T., et al. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: An alternative treatment. Plast. Reconstr. Surg. 107: 327, 2001.
22. Faulkner, J. A., Maxwell, L. C., and White, T. P. Adaptations in skeletal muscle. In J. W. McNamara, Jr. (Ed.), Muscle Adaptation in the Craniofacial Region. Monograph No. 8, Craniofacial Growth Series. Ann Arbor: University of Michigan, 1978.
23. Pedersen-Bjergaard, U., Nielsen, L. B., Jensen, K., et al. Calcitonin gene-related peptide, neurokinin A and substance P: Effects of nociception and neurogenic inflammation in human skin and temporal muscle. Peptides 12: 333, 1991.
24. Meunier, F. A., Colsante, C., Faille, L., et al. Upregulation of calcitonin gene-related peptide and mouse motor nerve terminals poisoned with botulinum type-A toxin. Pflugers Arch. 431: 297, 1996.
25. Van Rossum, D., Hanisch, U.-K., and Quirion, R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci. Biobehav. Rev. 21: 649, 1997.